Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 8/20 | 0.38 |
| ▸ | LPAR2 | Q9HBW0 | 6/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CDC25A | P30304 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23497214 | 1.00 | LPAR3 (0.38) | LPAR3LPAR2LPAR1TSHRCDC25A | |
| SCHEMBL23497248 | 1.00 | LPAR3 (0.38) | LPAR3LPAR2LPAR1TSHRCDC25A | |
| SCHEMBL8383286 | 0.88 | TSHR (0.40) | TSHR | |
| SCHEMBL23518533 | 0.87 | LPAR2 (0.30) | LPAR3LPAR2 | |
| SCHEMBL23518664 | 0.87 | LPAR2 (0.30) | LPAR3LPAR2 | |
| SCHEMBL20377389 | 0.85 | LPAR3 (0.38) | LPAR3LPAR2LPAR1CDC25A | |
| SCHEMBL31519188 | 0.83 | LPAR3 (0.35) | LPAR3LPAR2LPAR1 | |
| SCHEMBL11310369 | 0.79 | TSHR (0.34) | TSHR | |
| SCHEMBL24966318 | 0.79 | LPAR3 (0.55) | LPAR3LPAR2LPAR1TSHRCDC25A | |
| SCHEMBL24966575 | 0.79 | LPAR3 (0.55) | LPAR3LPAR2LPAR1TSHRCDC25A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12540148-B2 | Lipophosphonoxins, their preparation and use | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) | 2026-02-03 | — | — | US | disclosed |
| EP-4072681-B1 | LIPOPHOSPHONOXINS, THEIR PREPARATION AND USE | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I (CZ) | 2025-03-12 | — | — | EP | disclosed |
| US-20230028523-A1 | LIPOPHOSPHONOXINS, THEIR PREPARATION AND USE | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V. V. I. (CZ) | 2023-01-26 | — | — | US | disclosed |
| US-20230028523-A1 | LIPOPHOSPHONOXINS, THEIR PREPARATION AND USE | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V. V. I. (CZ) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230028523-A1 | LIPOPHOSPHONOXINS, THEIR PREPARATION AND USE | PHOSPHO1, PLA2G10, PLA2G1B | LPAR3 44/4885LPAR2 47/4885LPAR1 24/4885 |
| US-12540148-B2 | Lipophosphonoxins, their preparation and use | PLD1, LYPLA1, LPAR3 | LPAR3 3/4885LPAR2 25/4885LPAR1 9/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.